34 applied-physics-"https:"-"https:"-"https:"-"https:" Postdoctoral positions at Yale University
Sort by
Refine Your Search
-
. The ideal candidate will have completed medical school and have a strong background in science, with university studies in biology, chemistry, physics, computer science, or similar fields, and an interest in
-
applied science on enhancing natural Earth systems to create safe, effective, and scalable methods of reducing greenhouse gas concentrations in the atmosphere. The YCNCC mission strongly emphasizes
-
software or computation time). Important Dates and How to Apply The application deadline is on October 1, 2026. Please note that our review process may take several weeks. Applicants will be contacted
-
, and consortium-based datasets. Investigate environmental, lifestyle, metabolic, and omics-based exposures in relation to cancer and chronic diseases, including liver-related outcomes. Apply rigorous
-
, or qualitative research -Prior experience with software such as R/RStudio and Epic electronic health records -Able to lead independent projects but work collaboratively with team Process to Apply: If interested
-
C.V. and contact information for 2-3 references. The review process will begin immediately and will continue until the position is filled. Please apply by Friday, July 10 to guarantee full consideration
-
, crimes related to firearms, or violence prevention. Opportunities for advancement may be available contingent on success during the postdoctoral appointment. Application Instructions Please apply online
-
neurodevelopmental disorders. The successful candidate will develop and apply experimental and computational approaches to understand gene regulation and disease mechanisms in neural development and to evaluate
-
) contact information for three professional references via Interfolio. Please apply online. Application Process This institution is using Interfolio's Faculty Search to conduct this search. Applicants
-
drugs. Our focus is on cytokine-based drugs and immune checkpoint inhibitors. We use immune competent murine models and human cell culture systems for early drug development. We also study mechanisms